Physostigmine is a reversible cholinesterase inhibitor utilized clinically for its ability to increase parasympathetic activity, notably in the treatment of glaucoma and delayed gastric emptying, as well… Read more
Physostigmine is a reversible cholinesterase inhibitor utilized clinically for its ability to increase parasympathetic activity, notably in the treatment of glaucoma and delayed gastric emptying, as well as for reversing anticholinergic toxicity. As a potent active pharmaceutical ingredient, maintaining rigorous quality control during formulation development requires high-quality analytical support. This category provides access to essential reference standards for physostigmine and its various salt forms, such as salicylate and hemisulfate, which are critical for accurate identification and quantification. Furthermore, these products include related impurities and stable isotope labelled compounds, such as deuterium-labelled variants, which are indispensable in impurity profiling and quantitative mass spectrometry applications. By utilizing these materials, laboratories can ensure the precision of analytical testing, method validation, and the consistency of the active substance throughout the pharmaceutical manufacturing process.